CAV1 polymorphisms rs1049334, rs1049337, rs7804372 might be the potential risk in tumorigenicity of urinary cancer: a systematic review and meta-analysis
Conclusionrs1049334 polymorphismof CAV1 upgrade the risk of urinary cancer, while rs1049337 and rs7804372 polymorphisms may act as a protector of urinary cancer. Further large and well-designed studies in various populations are needed to confirm the results.
Source: Pathology Research and Practice - Category: Pathology Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Databases & Libraries | Gastric (Stomach) Cancer | Genetics | Liver | Lung Cancer | Men | Pathology | Science | Study | Urology & Nephrology